{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:16:39Z","timestamp":1790759799078,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82521104 and 82441001"],"award-info":[{"award-number":["82521104 and 82441001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences","award":["CI2023D003 and CI2023E005TS05"],"award-info":[{"award-number":["CI2023D003 and CI2023E005TS05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02663-z","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:15:20Z","timestamp":1769825720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chemoproteomics-based profiling elucidates the antimalarial effects of amodiaquine through disruption of glycolysis process in Plasmodium falciparum"],"prefix":"10.1186","volume":"24","author":[{"given":"Jianyou","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruishen","family":"Zhuge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"key":"2663_CR1","unstructured":"WHO. World malaria report 2025. Geneva, Switzerland: WHO; 2025. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240117822.\u00a0Cited 2025 Dec 4."},{"key":"2663_CR2","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s40265-018-0911-9","volume":"78","author":"EA Ashley","year":"2018","unstructured":"Ashley EA, Phyo AP. Drugs in development for malaria. Drugs. 2018;78:861\u201379.","journal-title":"Drugs"},{"key":"2663_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12936-019-2724-z","volume":"18","author":"EG Tse","year":"2019","unstructured":"Tse EG, Korsik M, Todd MH. The past, present and future of anti-malarial medicines. Malar J. 2019;18:93.","journal-title":"Malar J"},{"key":"2663_CR4","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/S1473-3099(14)70855-2","volume":"14","author":"RN Price","year":"2014","unstructured":"Price RN, von Seidlein L, Valecha N, Nosten F, Baird JK, White NJ. Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14:982\u201391.","journal-title":"Lancet Infect Dis"},{"key":"2663_CR5","doi-asserted-by":"crossref","unstructured":"Zhou W, Wang H, Yang Y, Chen ZS, Zou C, Zhang J. Chloroquine against malaria, cancers and viral diseases. Drug Discov Today. 2020;16;25(11):2012\u201322.","DOI":"10.1016\/j.drudis.2020.09.010"},{"key":"2663_CR6","first-page":"115","volume":"42","author":"AR Parhizgar","year":"2017","unstructured":"Parhizgar AR, Tahghighi A. Introducing new antimalarial analogues of chloroquine and amodiaquine: a narrative review. Iran J Med Sci. 2017;42:115\u201328.","journal-title":"Iran J Med Sci"},{"key":"2663_CR7","doi-asserted-by":"crossref","unstructured":"Olliaro P, Mussano P. Amodiaquine for treating malaria. Cochrane Database Syst Rev. 2000;2003(2):Cd000016.","DOI":"10.1002\/14651858.CD000016"},{"key":"2663_CR8","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/S0140-6736(05)65475-X","volume":"348","author":"NJ White","year":"1996","unstructured":"White NJ. Can amodiaquine be resurrected? Lancet. 1996;348:1184\u20135.","journal-title":"Lancet"},{"key":"2663_CR9","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/S0140-6736(96)06217-4","volume":"348","author":"P Olliaro","year":"1996","unstructured":"Olliaro P, Nevill C, LeBras J, Ringwald P, Mussano P, Garner P, et al. Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet. 1996;348:1196\u2013201.","journal-title":"Lancet"},{"key":"2663_CR10","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1517\/13543784.16.7.1079","volume":"16","author":"SB Sirima","year":"2007","unstructured":"Sirima SB, Gansan\u00e9 A. Artesunate-amodiaquine for the treatment of uncomplicated malaria. Expert Opin Investig Drugs. 2007;16:1079\u201385.","journal-title":"Expert Opin Investig Drugs"},{"key":"2663_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0140-6736(04)16680-4","volume":"364","author":"PG Kremsner","year":"2004","unstructured":"Kremsner PG, Krishna S. Antimalarial combinations. Lancet. 2004;364:285\u201394.","journal-title":"Lancet"},{"key":"2663_CR12","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1016\/j.ejmech.2010.04.011","volume":"45","author":"K Kaur","year":"2010","unstructured":"Kaur K, Jain M, Reddy R, Jain R. Quinolines and structurally related heterocycles as antimalarials. Eur J Med Chem. 2010;45:3245\u201364.","journal-title":"Eur J Med Chem"},{"key":"2663_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0163-7258(98)00012-6","volume":"79","author":"M Foley","year":"1998","unstructured":"Foley M, Tilley L. Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. Pharmacol Ther. 1998;79:55\u201387.","journal-title":"Pharmacol Ther"},{"key":"2663_CR14","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/S0006-2952(98)00184-1","volume":"56","author":"H Ginsburg","year":"1998","unstructured":"Ginsburg H, Famin O, Zhang J, Krugliak M. Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Biochem Pharmacol. 1998;56:1305\u201313.","journal-title":"Biochem Pharmacol"},{"key":"2663_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0166-6851(96)02655-2","volume":"80","author":"SR Hawley","year":"1996","unstructured":"Hawley SR, Bray PG, Park BK, Ward SA. Amodiaquine accumulation in Plasmodium falciparum as a possible explanation for its superior antimalarial activity over chloroquine. Mol Biochem Parasitol. 1996;80:15\u201325.","journal-title":"Mol Biochem Parasitol"},{"key":"2663_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/0014-5793(94)00921-X","volume":"352","author":"TJ Egan","year":"1994","unstructured":"Egan TJ, Ross DC, Adams PA. Quinoline anti-malarial drugs inhibit spontaneous formation of beta-haematin (malaria pigment). FEBS Lett. 1994;352:54\u20137.","journal-title":"FEBS Lett"},{"key":"2663_CR17","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/S0020-7519(02)00193-5","volume":"32","author":"DJ Sullivan","year":"2002","unstructured":"Sullivan DJ. Theories on malarial pigment formation and quinoline action. Int J Parasitol. 2002;32:1645\u201353.","journal-title":"Int J Parasitol"},{"key":"2663_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev.micro.51.1.97","volume":"51","author":"S Francis","year":"1997","unstructured":"Francis S, Sullivan D, Goldberg D. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu Rev Microbiol. 1997;51:97\u2013123.","journal-title":"Annu Rev Microbiol"},{"key":"2663_CR19","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.febslet.2011.04.042","volume":"585","author":"I Petersen","year":"2011","unstructured":"Petersen I, Eastman R, Lanzer M. Drug-resistant malaria: molecular mechanisms and implications for public health. FEBS Lett. 2011;585:1551\u201362.","journal-title":"FEBS Lett"},{"key":"2663_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1046\/j.1472-8206.2003.00164.x","volume":"17","author":"J Le Bras","year":"2003","unstructured":"Le Bras J, Durand R. The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum. Fundam Clin Pharmacol. 2003;17:147\u201353.","journal-title":"Fundam Clin Pharmacol"},{"key":"2663_CR21","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/jmv.25031","volume":"90","author":"Y Han","year":"2018","unstructured":"Han Y, Mesplede T, Xu H, Quan Y, Wainberg MA. The antimalarial drug amodiaquine possesses anti-ZIKA virus activities. J Med Virol. 2018;90:796\u2013802.","journal-title":"J Med Virol"},{"key":"2663_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.antiviral.2014.03.014","volume":"106","author":"S Boonyasuppayakorn","year":"2014","unstructured":"Boonyasuppayakorn S, Reichert ED, Manzano M, Nagarajan K, Padmanabhan R. Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity. Antiviral Res. 2014;106:125\u201334.","journal-title":"Antiviral Res"},{"key":"2663_CR23","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.4161\/auto.26506","volume":"9","author":"S Qiao","year":"2013","unstructured":"Qiao S, Tao S, de la Rojo Vega M, Park SL, Vonderfecht AA, Jacobs SL, et al. The antimalarial amodiaquine causes autophagic-lysosomal and proliferative blockade sensitizing human melanoma cells to starvation- and chemotherapy-induced cell death. Autophagy. 2013;9:2087\u2013102.","journal-title":"Autophagy"},{"key":"2663_CR24","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1111\/dom.13284","volume":"20","author":"HY Jung","year":"2018","unstructured":"Jung HY, Kim B, Ryu HG, Ji Y, Park S, Choi SH, et al. Amodiaquine improves insulin resistance and lipid metabolism in diabetic model mice. Diabetes Obes Metab. 2018;20:1688\u2013701.","journal-title":"Diabetes Obes Metab"},{"key":"2663_CR25","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"2663_CR26","doi-asserted-by":"publisher","first-page":"10111","DOI":"10.1038\/ncomms10111","volume":"6","author":"J Wang","year":"2015","unstructured":"Wang J, Zhang C-J, Chia WN, Loh CCY, Li Z, Lee YM, et al. Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum. Nat Commun. 2015;6:10111.","journal-title":"Nat Commun"},{"key":"2663_CR27","first-page":"30","volume":"9","author":"P Gao","year":"2022","unstructured":"Gao P, Liu Y-Q, Xiao W, Xia F, Chen J-Y, Gu L-W, et al. Identification of antimalarial targets of chloroquine by a combined deconvolution strategy of ABPP and MS-CETSA. Mil Med Res. 2022;9:30.","journal-title":"Mil Med Res"},{"key":"2663_CR28","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"W Trager","year":"1976","unstructured":"Trager W, Jensen JB. Human malaria parasites in continuous culture. Science. 1976;193:673\u20135.","journal-title":"Science"},{"key":"2663_CR29","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","volume":"48","author":"M Smilkstein","year":"2004","unstructured":"Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother. 2004;48:1803\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"2663_CR30","doi-asserted-by":"publisher","first-page":"108296","DOI":"10.1016\/j.cclet.2023.108296","volume":"34","author":"P Gao","year":"2023","unstructured":"Gao P, Chen J, Sun P, Wang J, Tang H, Xia F, et al. Chemical proteomic profiling with photoaffinity labeling strategy identifies antimalarial targets of artemisinin. Chin Chem Lett. 2023;34:108296.","journal-title":"Chin Chem Lett"},{"key":"2663_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.eng.2023.06.001","volume":"31","author":"P Gao","year":"2023","unstructured":"Gao P, Wang J, Chen J, Gu L, Wang C, Xu L, et al. Profiling the antimalarial mechanism of artemisinin by identifying crucial target proteins. Engineering. 2023;31:86\u201397.","journal-title":"Engineering"},{"key":"2663_CR32","doi-asserted-by":"crossref","unstructured":"Toro-Moreno M, Sylvester K, Srivastava T, Posfai D, Derbyshire ER. RNA-seq analysis illuminates the early stages of plasmodium liver infection. mBio 2020;4;11(1):e03234-19 .","DOI":"10.1128\/mBio.03234-19"},{"key":"2663_CR33","first-page":"22","volume":"9","author":"P Luo","year":"2022","unstructured":"Luo P, Zhang Q, Zhong TY, Chen JY, Zhang JZ, Tian Y, et al. Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect. Mil Med Res. 2022;9:22.","journal-title":"Mil Med Res"},{"key":"2663_CR34","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1021\/acsinfecdis.6b00101","volume":"2","author":"T Sakata-Kato","year":"2016","unstructured":"Sakata-Kato T, Wirth DF. A novel methodology for bioenergetic analysis of Plasmodium falciparum reveals a glucose-regulated metabolic shift and enables mode of action analyses of mitochondrial inhibitors. ACS Infect Dis. 2016;2:903\u201316.","journal-title":"ACS Infect Dis"},{"key":"2663_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0163-7258(97)00084-3","volume":"77","author":"PM O'Neill","year":"1998","unstructured":"O\u2019Neill PM, Bray PG, Hawley SR, Ward SA, Park BK. 4-aminoquinolines\u2013past, present, and future: a chemical perspective. Pharmacol Ther. 1998;77:29\u201358.","journal-title":"Pharmacol Ther"},{"key":"2663_CR36","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/febs.13615","volume":"283","author":"DD van Niekerk","year":"2016","unstructured":"van Niekerk DD, Penkler GP, du Toit F, Snoep JL. Targeting glycolysis in the malaria parasite Plasmodium falciparum. FEBS J. 2016;283:634\u201346.","journal-title":"FEBS J"},{"key":"2663_CR37","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1080\/07391102.2018.1471417","volume":"37","author":"S Saxena","year":"2019","unstructured":"Saxena S, Durgam L, Guruprasad L. Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH). J Biomol Struct Dyn. 2019;37:1783\u201399.","journal-title":"J Biomol Struct Dyn"},{"key":"2663_CR38","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1107\/S0907444905018317","volume":"61","author":"JF Satchell","year":"2005","unstructured":"Satchell JF, Malby RL, Luo CS, Adisa A, Alpyurek AE, Klonis N, et al. Structure of glyceraldehyde-3-phosphate dehydrogenase from Plasmodium falciparum. Acta Crystallogr D Biol Crystallogr. 2005;61:1213\u201321.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"2663_CR39","doi-asserted-by":"crossref","unstructured":"Biddau M, M\u00fcller S. Carbon Metabolism of Plasmodium falciparum. Comprehensive Analysis of Parasite Biology: From Metabolism to Drug Discovery: From Metabolism to Drug Discovery. Wiley-VCHVerlag GmbH & Co. KGaA, 2016, pp. 371\u2013398.","DOI":"10.1002\/9783527694082.ch16"},{"key":"2663_CR40","doi-asserted-by":"crossref","unstructured":"Huang J, Yuan Y, Zhao N, Pu D, Tang Q, Zhang S, et al. Orthosteric-allosteric dual inhibitors of PfHT1 as selective antimalarial agents. Proc Natl Acad Sci U S A. 2021;118(3):e2017749118.","DOI":"10.1073\/pnas.2017749118"},{"key":"2663_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.aca.2012.06.016","volume":"739","author":"S Vo Duy","year":"2012","unstructured":"Vo Duy S, Besteiro S, Berry L, Perigaud C, Bressolle F, Vial HJ, et al. A quantitative liquid chromatography tandem mass spectrometry method for metabolomic analysis of Plasmodium falciparum lipid related metabolites. Anal Chim Acta. 2012;739:47\u201355.","journal-title":"Anal Chim Acta"},{"key":"2663_CR42","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1016\/S1473-3099(19)30261-0","volume":"19","author":"MD Conrad","year":"2019","unstructured":"Conrad MD, Rosenthal PJ. Antimalarial drug resistance in Africa: the calm before the storm? Lancet Infect Dis. 2019;19:e338\u201351.","journal-title":"Lancet Infect Dis"},{"key":"2663_CR43","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.2174\/156802611795429194","volume":"11","author":"JN Burrows","year":"2011","unstructured":"Burrows JN, Chibale K, Wells TN. The state of the art in anti-malarial drug discovery and development. Curr Top Med Chem. 2011;11:1226\u201354.","journal-title":"Curr Top Med Chem"},{"key":"2663_CR44","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1093\/jac\/dkv018","volume":"70","author":"MA Al-Bari","year":"2015","unstructured":"Al-Bari MA. Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases. J Antimicrob Chemother. 2015;70:1608\u201321.","journal-title":"J Antimicrob Chemother"},{"key":"2663_CR45","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0020-7519(96)00152-X","volume":"27","author":"M Foley","year":"1997","unstructured":"Foley M, Tilley L. Quinoline antimalarials: mechanisms of action and resistance. Int J Parasitol. 1997;27:231\u201340.","journal-title":"Int J Parasitol"},{"key":"2663_CR46","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1021\/acsinfecdis.8b00279","volume":"5","author":"J Okombo","year":"2019","unstructured":"Okombo J, Brunschwig C, Singh K, Dziwornu GA, Barnard L, Njoroge M, et al. Antimalarial pyrido[1,2- a]benzimidazole derivatives with Mannich base side chains: synthesis, pharmacological evaluation, and reactive metabolite trapping studies. ACS Infect Dis. 2019;5:372\u201384.","journal-title":"ACS Infect Dis"},{"key":"2663_CR47","doi-asserted-by":"publisher","first-page":"e202301642","DOI":"10.1002\/chem.202301642","volume":"29","author":"L Colina-Vegas","year":"2023","unstructured":"Colina-Vegas L, da Cruz BSM, de Souza PC, Isis Barros A, Araujo Nobrega J, Navarro M, et al. Antimalarial Agents Derived from Metal-Amodiaquine Complexes with Activity in Multiple Stages of the Plasmodium Life Cycle. Chemistry. 2023;29:e202301642.","journal-title":"Chemistry"},{"key":"2663_CR48","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1021\/jm00035a017","volume":"37","author":"PM O'Neill","year":"1994","unstructured":"O\u2019Neill PM, Harrison AC, Storr RC, Hawley SR, Ward SA, Park BK. The effect of fluorine substitution on the metabolism and antimalarial activity of amodiaquine. J Med Chem. 1994;37:1362\u201370.","journal-title":"J Med Chem"},{"key":"2663_CR49","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/0006-2952(96)00354-1","volume":"52","author":"SR Hawley","year":"1996","unstructured":"Hawley SR, Bray PG, O\u2019Neill PM, Park BK, Ward SA. The role of drug accumulation in 4-aminoquinoline antimalarial potency. The influence of structural substitution and physicochemical properties. Biochem Pharmacol. 1996;52:723\u201333.","journal-title":"Biochem Pharmacol"},{"key":"2663_CR50","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1021\/jm010842o","volume":"44","author":"S Delarue","year":"2001","unstructured":"Delarue S, Girault S, Maes L, Debreu-Fontaine MA, Labae\u00efd M, Grellier P, et al. Synthesis and in vitro and in vivo antimalarial activity of new 4-anilinoquinolines. J Med Chem. 2001;44:2827\u201333.","journal-title":"J Med Chem"},{"key":"2663_CR51","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.1021\/jm030796n","volume":"46","author":"PM O'Neill","year":"2003","unstructured":"O\u2019Neill PM, Mukhtar A, Stocks PA, Randle LE, Hindley S, Ward SA, et al. Isoquine and related amodiaquine analogues: a new generation of improved 4-aminoquinoline antimalarials. J Med Chem. 2003;46:4933\u201345.","journal-title":"J Med Chem"},{"key":"2663_CR52","doi-asserted-by":"publisher","first-page":"R108","DOI":"10.1186\/gb-2012-13-11-r108","volume":"13","author":"SC Oehring","year":"2012","unstructured":"Oehring SC, Woodcroft BJ, Moes S, Wetzel J, Dietz O, Pulfer A, et al. Organellar proteomics reveals hundreds of novel nuclear proteins in the malaria parasite Plasmodium falciparum. Genome Biol. 2012;13:R108.","journal-title":"Genome Biol"},{"key":"2663_CR53","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12936-018-2336-z","volume":"17","author":"KA Frith","year":"2018","unstructured":"Frith KA, Fogel R, Goldring JPD, Krause RGE, Khati M, Hoppe H, et al. Towards development of aptamers that specifically bind to lactate dehydrogenase of Plasmodium falciparum through epitopic targeting. Malar J. 2018;17:191.","journal-title":"Malar J"},{"key":"2663_CR54","doi-asserted-by":"publisher","first-page":"200302","DOI":"10.1098\/rsob.200302","volume":"10","author":"M Rojas-Pirela","year":"2020","unstructured":"Rojas-Pirela M, Andrade-Alvi\u00e1rez D, Rojas V, Kemmerling U, C\u00e1ceres AJ, Michels PA, et al. Phosphoglycerate kinase: structural aspects and functions, with special emphasis on the enzyme from Kinetoplastea. Open Biol. 2020;10:200302.","journal-title":"Open Biol"},{"key":"2663_CR55","first-page":"451065","volume":"2014","author":"A Alam","year":"2014","unstructured":"Alam A, Neyaz MK, Ikramul Hasan S. Exploiting unique structural and functional properties of malarial glycolytic enzymes for antimalarial drug development. Malar Res Treat. 2014;2014:451065.","journal-title":"Malar Res Treat"},{"key":"2663_CR56","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.exppara.2017.05.007","volume":"179","author":"RGE Krause","year":"2017","unstructured":"Krause RGE, Hurdayal R, Choveaux D, Przyborski JM, Coetzer THT, Goldring JPD. Plasmodium glyceraldehyde-3-phosphate dehydrogenase: a potential malaria diagnostic target. Exp Parasitol. 2017;179:7\u201319.","journal-title":"Exp Parasitol"},{"key":"2663_CR57","doi-asserted-by":"publisher","first-page":"e1010803","DOI":"10.1371\/journal.ppat.1010803","volume":"18","author":"AJ Jezewski","year":"2022","unstructured":"Jezewski AJ, Guggisberg AM, Hodge DM, Ghebremichael N, John GN, McLellan LK, et al. GAPDH mediates drug resistance and metabolism in Plasmodium falciparum malaria parasites. PLoS Pathog. 2022;18:e1010803.","journal-title":"PLoS Pathog"},{"key":"2663_CR58","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1007\/s00436-022-07673-7","volume":"121","author":"L Mamede","year":"2022","unstructured":"Mamede L, Fall F, Schoumacher M, Ledoux A, De Tullio P, Quetin-Leclercq J, et al. Recent metabolomic developments for antimalarial drug discovery. Parasitol Res. 2022;121:3351\u201380.","journal-title":"Parasitol Res"},{"key":"2663_CR59","doi-asserted-by":"crossref","unstructured":"Phillips MA, Hapuarachchi SV, Cobbold SA, Shafik SH, Dennis ASM, McConville MJ, Martin RE, Kirk K, Lehane AM. The malaria parasite's lactate transporter PfFNT is the target of antiplasmodial compounds identified in whole cell phenotypic screens. PLOS Pathogens. 2017;13(2):e1006180.","DOI":"10.1371\/journal.ppat.1006180"},{"key":"2663_CR60","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(12)60034-8","volume":"379","author":"CJL Murray","year":"2012","unstructured":"Murray CJL, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, et al. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet. 2012;379:413\u201331.","journal-title":"Lancet"},{"key":"2663_CR61","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00228-007-0452-8","volume":"64","author":"C Orrell","year":"2008","unstructured":"Orrell C, Little F, Smith P, Folb P, Taylor W, Olliaro P, et al. Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers. Eur J Clin Pharmacol. 2008;64:683\u201390.","journal-title":"Eur J Clin Pharmacol"},{"key":"2663_CR62","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00228-009-0656-1","volume":"65","author":"V Navaratnam","year":"2009","unstructured":"Navaratnam V, Ramanathan S, Wahab MS, Siew Hua G, Mansor SM, Kiechel JR, et al. Tolerability and pharmacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers. Eur J Clin Pharmacol. 2009;65:809\u201321.","journal-title":"Eur J Clin Pharmacol"},{"key":"2663_CR63","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ejmech.2012.05.007","volume":"54","author":"F Samari","year":"2012","unstructured":"Samari F, Shamsipur M, Hemmateenejad B, Khayamian T, Gharaghani S. Investigation of the interaction between amodiaquine and human serum albumin by fluorescence spectroscopy and molecular modeling. Eur J Med Chem. 2012;54:255\u201363.","journal-title":"Eur J Med Chem"},{"key":"2663_CR64","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/14787210.2021.1962291","volume":"20","author":"C Rasmussen","year":"2022","unstructured":"Rasmussen C, Alonso P, Ringwald P. Current and emerging strategies to combat antimalarial resistance. Expert Rev Anti-Infect Ther. 2022;20:353\u201372.","journal-title":"Expert Rev Anti-Infect Ther"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02663-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02663-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02663-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:03:35Z","timestamp":1772193815000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02663-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2663"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02663-z","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"28 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}